Skip to main content

Peer Review reports

From: Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

Original Submission
19 Oct 2021 Submitted Original manuscript
6 Nov 2021 Reviewed Reviewer Report - James Wason
13 Dec 2021 Reviewed Reviewer Report - Research Square Reviewer 1
13 Feb 2022 Reviewed Reviewer Report - James A Watson
9 Mar 2022 Author responded Author comments - James M McGree
Resubmission - Version 2
9 Mar 2022 Submitted Manuscript version 2
Publishing
10 Mar 2022 Editorially accepted
27 Apr 2022 Article published 10.1186/s13063-022-06167-2

You can find further information about peer review here.

Back to article page